KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Merck (MRK) Return on Sales (2016 - 2025)

Historic Return on Sales for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to 0.33%.

  • Merck's Return on Sales rose 1500.0% to 0.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.3%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.27% for FY2024, which is 2600.0% up from last year.
  • Latest data reveals that Merck reported Return on Sales of 0.33% as of Q3 2025, which was up 1500.0% from 0.28% recorded in Q2 2025.
  • Merck's Return on Sales' 5-year high stood at 0.34% during Q2 2024, with a 5-year trough of 0.4% in Q2 2023.
  • For the 5-year period, Merck's Return on Sales averaged around 0.12%, with its median value being 0.12% (2021).
  • Its Return on Sales has fluctuated over the past 5 years, first plummeted by -4000bps in 2023, then surged by 7400bps in 2024.
  • Quarter analysis of 5 years shows Merck's Return on Sales stood at 0.0% in 2021, then soared by 77bps to 0.0% in 2022, then plummeted by -7871bps to 0.08% in 2023, then surged by 386bps to 0.24% in 2024, then soared by 40bps to 0.33% in 2025.
  • Its Return on Sales stands at 0.33% for Q3 2025, versus 0.28% for Q2 2025 and 0.33% for Q1 2025.